endometrial cancer | GenomeWeb

endometrial cancer

A team from Mount Sinai and Swift Biosciences used targeted sequencing to detect cancer mutations in uterine lavage fluid.

Two separate studies concluded that in most SEO cancer cases what they are seeing are two separate early-stage tumors, instead of late-stage cancer.

The SBIR grant could be worth as much as $2.3 million and will help PapGene develop and commercialize its proprietary ovarian and endometrial cancer detection test.

Teams tracked immune cell infiltration, PD-L1 expression, and more in tumors from BRCA1/2-mutated ovarian cancers or mutation-rich endometrial cancer subtypes.

The goal is to design personalized noninvasive ddPCR-based panels to monitor ctDNA levels throughout a patient's disease.

Johns Hopkins researchers are using sequencing to detect cancer mutations in cell-free DNA from vaginal fluids collected in tampons.

NEW YORK (GenomeWeb) – OvaGene and Indian life sciences firm iLife Discoveries today announced an alliance to bring gene-based assays targeting ovarian, endometrial, and cervical cancer to India.

NEW YORK (GenomeWeb) – Invitae and Nanopharmacia today announced an exclusive partnership to provide access to Invitae's genetic tests for hereditary cancers in Mexico.

NEW YORK (GenomeWeb News) – A pair of Nature Genetics studies by independent research teams explored the genetic glitches characterizing cancers that affect the biliary tract or bile ducts of the liver.

Researchers from the MD Anderson Cancer Center are poised to begin a phase I study of a novel siRNA-based therapeutic for cancer, opting to handle the first stage of human testing on their own before pursing an industry alliance, Gene Silencing News has learned.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.